Exploring hypoxia-related genes in spinal cord injury: a pathway to new therapeutic targets
This study constructed a diagnostic model that confirmed <i>Casp6</i>, <i>Pkm</i>, <i>Cxcr4</i>, and <i>Hexa</i> as important biomarkers for SCI. The findings provide valuable insights into SCI pathogenesis and pave the way for novel treatment strategies. The integration of multi-omics data and comprehensive bioinformatics analyses offers a robust framework for identifying therapeutic targets and improving patient outcomes.
Authors
- Ningyi Ma
- Shihuan Cheng (ORCID: https://orcid.org/0000-0001-7661-1543)
- Yukai Zheng (ORCID: https://orcid.org/0000-0003-1511-4572)
- Mengmeng Xu
- Le Li (ORCID: https://orcid.org/0000-0002-0975-615X)
Institutions
- Union Hospital (HK)
- Jilin University (CN)
- First Hospital of Jilin University (CN)
Publication Details
- Journal
- Frontiers in Molecular Neuroscience
- Published
- 2025-05-20
- DOI
- https://doi.org/10.3389/fnmol.2025.1565430
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00